[1] Beers and Berkow, The Merck Manual (Whitehouse Station, NJ: Merck Research Laboratories, 1999), 750-6.

[2] Fitzpatrick, Johnson, Wolff, Color Atlas and Synopsis of Clinical Dermatology (City: McGraw Hill, 1997), 792-809.

[3] Beers and Berkow, The Merck Manual (Whitehouse Station, NJ: Merck Research Laboratories, 1999), 1293-5

[4] Thein DJ, Hurt WC. Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis. Oral Surg Oral Med Oral Pathol. 1984 Dec;58(6):659-66.

[5] Bartolotta S, Garcia CC, Candurra NA, Damonte EB.

Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch Virol. 2001;146(4):777-90.

[6] Conroy, Yarnell, Berg-Nowicki, Naturopathic Approach to Ophthalomology and Otolaryngology (Wenatchee, WA: Healing Mountain , 2002), 248-51.

[7] McCune MA, Perry HO, Muller SA, O'Fallon WM.Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis. 1984 Oct;34(4):366-73.           

[8] Hornung B, Amtmann E, Sauer G. J Gen Virol. 1994 Feb;75 ( Pt 2):353-61. Lauric acid inhibits the maturation of vesicular stomatitis virus.

[9] Bartolotta S, Garcia CC, Candurra NA, Damonte EB. Arch Virol.Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. 2001;146(4):777-90.

[10] Hovi T. Topical treatment of recurrent mucocutaneous herpes with ascorbic acid-contianing solution. Antiviral Research 1995;27:263-70.

[11] Eby GA, Halcomb WW. Med Hypotheses. 1985 Jun;17(2):157-65. Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols.

[12] Wahba A. Topical application of zinc-solutions: a new treatment for herpes simplex infections of the skin? Acta Derm Venereol. 1980;60(2):175-77.

[13] Brody I. Topical treatment of recurrent herpes simplex and post-herpetic erythema multiforme with low concentrations of zinc sulphate solution. Br J Dermatol. 1981 Feb;104(2):191-4.

[14] Benencia F, Courreges MC.  In vitro and in vivo activity of eugenol on human herpesvirus. Phytother Res. 2000 Nov;14(7):495-500.

[15] Bourne KZ, Bourne N, Reising SF, Stanberry LR. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral Res. 1999 Jul;42(3):219-26.

[16] Duarte ME, Noseda DG, Noseda MD, Tulio S, Pujol CA, Damonte EB. Inhibitory effect of sulfated galactans from the marine alga Bostrychia montagnei on herpes simplex virus replication in vitro. Phytomedicine. 2001 Jan;8(1):53-8.

[17] Serkedjieva J. Antiviral activity of the red marine alga Ceramium rubrum. Phytother Res. 2004 Jun;18(6):480-3.

[18] Hirabayashi K, Iwata S, Matsumoto H, Mori T, Shibata S, Baba M, Ito M, Shigeta S, Nakashima H, Yamamoto N. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chem Pharm Bull (Tokyo). 1991 Jan;39(1):112-5.

[19] Pompei R, Pani A, Flore O, Marcialis MA, Loddo B.

 Antiviral activity of glycyrrhizic acid.  Experientia. 1980 Mar 15;36(3):304.

[20] Dimitrova Z, Dimov B, Manolova N, Pancheva S, Ilieva D, Shishkov S. Antiherpes effect of Melissa officinalis L. extracts. Acta Microbiol Bulg. 1993;29:65-72.